AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21320198 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine monitoring)
Number of subjects: 120
Study 18653687 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D Flow MR imaging
Number of subjects: 0
Study 16984498 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg s.c.
Number of subjects: 14
Study 16984498 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 14
Study 14962329 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (200 microg.kg(‐1).min(‐1))
Number of subjects: 56
Study 14962329 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (1.5‐2.5%)
Number of subjects: 56
Study 10924726 — intervention group
Group type: EXPERIMENTAL
Intervention: DSA (dextran sulphate adsorption)
Number of subjects: 8
Study 10924726 — intervention group
Group type: EXPERIMENTAL
Intervention: IMAL (immunoadsorption)
Number of subjects: 8
Study 10924726 — intervention group
Group type: EXPERIMENTAL
Intervention: DALI (direct adsorption of lipoproteins)
Number of subjects: 8
Study 9066740 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-operative adjuvant chemotherapy (PAC) with CEF (cyclophosphamide 600 mg/sqm, epidoxorubicin 60 mg/sqm, 5-fluorouracil 600 mg/sqm)
Number of subjects: 375
Study 9066740 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PAC)
Number of subjects: 375
Study 8394470 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with 10% of total dose (T) of pipecuronium
Number of subjects: 52
Study 8394470 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with 5%, 15%, or 20% of total dose (T) of pipecuronium
Number of subjects: 52
Study 8394470 — intervention group
Group type: COMPARATOR
Intervention: No priming
Number of subjects: 52
Study 3523393 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal iontophoresis of vincristine
Number of subjects: 20
Study 3523393 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 29174864 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20-40mg/day)
Number of subjects: 42
Study 29174864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 26859610 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 133
Study 26859610 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 133
Study 24950841 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 360
Study 24950841 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 360
Study 22129564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated proton therapy (IMPT)
Number of subjects: 16
Study 22129564 — intervention group
Group type: COMPARATOR
Intervention: Passive scattering proton therapy (PSPT)
Number of subjects: 16
Study 20925201 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 6 mg/kg body weight
Number of subjects: 54
Study 20925201 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg
Number of subjects: 54
Study 20925201 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) and Albendazole
Number of subjects: 54
Study 18789649 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein- and energy-enriched diet and snacks
Number of subjects: 65
Study 18789649 — intervention group
Group type: COMPARATOR
Intervention: Standard food of the nursing home
Number of subjects: 65
Study 15549326 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/day for 6 weeks)
Number of subjects: 29
Study 15549326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 12416663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular and strength programme (CSP)
Number of subjects: 96
Study 12416663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise programme (CEP)
Number of subjects: 96
Study 12416663 — intervention group
Group type: COMPARATOR
Intervention: Baseline exercise programme (BEP)
Number of subjects: 96
Study 10333947 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone (600 mg)
Number of subjects: 16
Study 10333947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8975299 — intervention group
Group type: EXPERIMENTAL
Intervention: FSE-CHESS
Number of subjects: 32
Study 8975299 — intervention group
Group type: EXPERIMENTAL
Intervention: STIR-FSE
Number of subjects: 32
Study 8975299 — intervention group
Group type: COMPARATOR
Intervention: T1-weighted SE
Number of subjects: 32
Study 1832287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) 3 pmol kg-1 min-1
Number of subjects: 8
Study 1832287 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) 15 pmol kg-1 min-1
Number of subjects: 8
Study 1832287 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (10 mg slow i.v.)
Number of subjects: 8
Study 6187064 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprinosine administered for 60 days
Number of subjects: 11
Study 6187064 — intervention group
Group type: COMPARATOR
Intervention: Prednisone administered for 60 days (Control)
Number of subjects: 11
Study 6187064 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF examination for IgG oligoclonal bands
Number of subjects: 11
Study 31150084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Psychotherapy (GPT)
Number of subjects: 433
Study 31150084 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Clinical Management (CM)
Number of subjects: 433
Study 31150084 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 433
Study 31150084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433
Study 31150084 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory
Number of subjects: 433
Study 29069046 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniotomy surgery (Group A, n=21)
Number of subjects: 63
Study 29069046 — intervention group
Group type: EXPERIMENTAL
Intervention: Burr hole, urokinase infusion and catheter drainage (Group B, n=22)
Number of subjects: 63
Study 29069046 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroendoscopic surgery (Group C, n=20)
Number of subjects: 63
Study 29069046 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 63
Study 26607842 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 56
Study 26607842 — intervention group
Group type: COMPARATOR
Intervention: Control (without PRF)
Number of subjects: 56
Study 26607842 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PRF and Control
Number of subjects: 56
Study 23312343 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete thymectomy
Number of subjects: 32
Study 23312343 — intervention group
Group type: COMPARATOR
Intervention: No thymectomy
Number of subjects: 32
Study 23312343 — intervention group
Group type: COMPARATOR
Intervention: Partial thymectomy
Number of subjects: 32
Study 21727100 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardization of medication-ordering, reliable medication-dispensing processes, reliable medication-administration processes, improvement of patient safety culture, clinical decision support.
Number of subjects: 13
Study 19211654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Exercise Programme (DEP)
Number of subjects: 50
Study 19211654 — intervention group
Group type: COMPARATOR
Intervention: Conventional joint rehabilitation group
Number of subjects: 50
Study 15915004 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg clonazepam
Number of subjects: 10
Study 15915004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 14601351 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy self-help facilitated by practice nurses
Number of subjects: 0
Study 14601351 — intervention group
Group type: COMPARATOR
Intervention: Ordinary care by GPs
Number of subjects: 0
Study 10387403 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment trials
Number of subjects: 0
Study 10387403 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention trials
Number of subjects: 0
Study 10387403 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow inclusion criteria
Number of subjects: 0
Study 10387403 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective participation in treatment RCTs
Number of subjects: 0
Study 8699577 — intervention group
Group type: EXPERIMENTAL
Intervention: K-Y diet (rice-lentil-yogurt)
Number of subjects: 30
Study 8699577 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk protein-based lactose free formula
Number of subjects: 30
Study 8699577 — intervention group
Group type: COMPARATOR
Intervention: Soy protein formula
Number of subjects: 30
Study 2025847 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery
Number of subjects: 215
Study 2025847 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive radiation therapy
Number of subjects: 215
Study 2025847 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 215
Study 2025847 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 215
Study 2025847 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection plus irradiation
Number of subjects: 215
Study 2025847 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated irradiation with less intense chemotherapy
Number of subjects: 215
Study 2025847 — intervention group
Group type: COMPARATOR
Intervention: Hyperfractionated irradiation with simultaneous chemotherapy
Number of subjects: 215
Study 6625781 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oxygen treatment (COT)
Number of subjects: 150
Study 6625781 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal oxygen treatment (NOT)
Number of subjects: 150
Study 6625781 — intervention group
Group type: COMPARATOR
Intervention: Both COT and NOT
Number of subjects: 150
Study 31586204 — intervention group
Group type: EXPERIMENTAL
Intervention: Using sunscreen (Condition 1, n = 259)
Number of subjects: 1044
Study 31586204 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking shade (Condition 2, n = 245)
Number of subjects: 1044
Study 31586204 — intervention group
Group type: EXPERIMENTAL
Intervention: Covering up (Condition 3, n = 289)
Number of subjects: 1044
Study 31586204 — intervention group
Group type: COMPARATOR
Intervention: Multibehavior message (Condition 4, Control, n = 251)
Number of subjects: 1044
Study 29975462 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranirestat (40 mg/day)
Number of subjects: 557
Study 29975462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 557
Study 28681612 — intervention group
Group type: EXPERIMENTAL
Intervention: M + A group (mothers and adolescents)
Number of subjects: 1455
Study 28681612 — intervention group
Group type: EXPERIMENTAL
Intervention: A group (adolescents only)
Number of subjects: 1455
Study 28681612 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1455
Study 25656503 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based contingency management program (CM)
Number of subjects: 17
Study 25656503 — intervention group
Group type: COMPARATOR
Intervention: Phone-delivered cessation counseling program (SCHB)
Number of subjects: 17
Study 24973990 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced Forced Expiratory Volume in 1 Second (FEV1)
Number of subjects: 1307
Study 24973990 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral Artery Disease (PAD)
Number of subjects: 1307
Study 24973990 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined reduced FEV1 and PAD
Number of subjects: 1307
Study 21638103 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosynoviorthesis
Number of subjects: 0
Study 19207347 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-Step directive approach to facilitating AA
Number of subjects: 169
Study 19207347 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement approach to facilitating AA
Number of subjects: 169
Study 19207347 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 169
Study 17169168 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing of 100% O2
Number of subjects: 0
Study 17169168 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 0
Study 15868260 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 40
Study 15868260 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic resection (LR)
Number of subjects: 40
Study 11874605 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive positive‐pressure ventilation (IPPV)
Number of subjects: 0
Study 11874605 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive‐pressure ventilation (NPPV)
Number of subjects: 0
Study 11874605 — intervention group
Group type: COMPARATOR
Intervention: IPPV
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bidisomide co-administration with breakfast
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bidisomide infusion with high fat breakfast
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bidisomide co-administration with viscous homogenized solid meals
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral non-caloric hydroxypropyl methylcellulose meals
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral, duodenal, and mid-jejunal administration of disopyramide in dogs
Number of subjects: 0
Study 9523307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bidisomide administration in dogs with solid meal co-administration
Number of subjects: 0
Study 7639300 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 13
Study 7639300 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 13
Study 2678210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (beta blocker)
Number of subjects: 47
Study 2678210 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 47
Study 2678210 — intervention group
Group type: COMPARATOR
Intervention: Combined beta blocker and relaxation therapy
Number of subjects: 47
Study 2678210 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 47
Study 577445 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg daily
Number of subjects: 42
Study 577445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 30479099 — intervention group
Group type: EXPERIMENTAL
Intervention: Less radical hysterectomy (RH) regarding parametrectomy
Number of subjects: 0
Study 30479099 — intervention group
Group type: EXPERIMENTAL
Intervention: Trachelectomy (vaginal or abdominal)
Number of subjects: 0
Study 30479099 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 0
Study 30479099 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive surgery
Number of subjects: 0
Study 29171487 — intervention group
Group type: EXPERIMENTAL
Intervention: neuromultivit and basic therapy
Number of subjects: 100
Study 29171487 — intervention group
Group type: COMPARATOR
Intervention: basic therapy
Number of subjects: 100
Study 25653188 — intervention group
Group type: EXPERIMENTAL
Intervention: Home HPV test
Number of subjects: 63
Study 25653188 — intervention group
Group type: COMPARATOR
Intervention: Clinic Pap test
Number of subjects: 63
Study 23397863 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hyperoxia (NBO), 100% oxygen (O2) at 1 atmosphere absolute (atm abs) for 90 minutes
Number of subjects: 18
Study 23397863 — intervention group
Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 18
Study 22139799 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with lidocaine spray (10gr/100ml) in Group A (≤65 years)
Number of subjects: 248
Study 22139799 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with lidocaine spray (10gr/100ml) in Group B (>65 years)
Number of subjects: 248
Study 19695646 — intervention group
Group type: EXPERIMENTAL
Intervention: Full spectrum therapy with pelvic floor muscle training
Number of subjects: 63
Study 19695646 — intervention group
Group type: COMPARATOR
Intervention: Full spectrum therapy without pelvic floor muscle training (Control)
Number of subjects: 63
Study 16645428 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliéva (Mahonia aquifolium extract) topical cream, applied twice a day for 12 weeks
Number of subjects: 200
Study 16645428 — intervention group
Group type: COMPARATOR
Intervention: Placebo topical cream, applied twice a day for 12 weeks
Number of subjects: 200
Study 11895160 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) supplemented with soybean oil (SO, Lipovenoess 10% PLR; 1.0 g/kgBW per day; n = 20)
Number of subjects: 44
Study 11895160 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) supplemented with a combination of fish oil (FO, Omegaven; 0.2 g/kgBW per day) and soybean oil (SO, Lipovenoes 10% PLR; 0.8 g/kgBW per day; n = 24)
Number of subjects: 44
Study 9495408 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. droperidol
Number of subjects: 97
Study 9495408 — intervention group
Group type: EXPERIMENTAL
Intervention: epidural droperidol
Number of subjects: 97
Study 9495408 — intervention group
Group type: COMPARATOR
Intervention: no droperidol injection
Number of subjects: 97
Study 8535553 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg three times daily
Number of subjects: 15
Study 8535553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2118403 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of raised toilet seat
Number of subjects: 744
Study 2118403 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of teapot tipper
Number of subjects: 744
Study 2118403 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of tap turner
Number of subjects: 744
Study 2118403 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of double handled saucepan
Number of subjects: 744
Study 2118403 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of shoe horn
Number of subjects: 744
Study 300048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (twice daily dosage for 5 days)
Number of subjects: 0
Study 300048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (twice daily dosage)
Number of subjects: 0
Study 27162452 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar block
Number of subjects: 152
Study 27162452 — intervention group
Group type: COMPARATOR
Intervention: Posterior sub-Tenon block
Number of subjects: 152
Study 24570217 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-health program (MoodCare)
Number of subjects: 121
Study 24570217 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 121
Study 23973636 — intervention group
Group type: EXPERIMENTAL
Intervention: American ginseng (AG) 3g daily for 12 weeks
Number of subjects: 64
Study 23973636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 20713813 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband UV-B treatment 3 times per week
Number of subjects: 60
Study 20713813 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 17544842 — intervention group
Group type: EXPERIMENTAL
Intervention: 20m square shuttle run test (SST)
Number of subjects: 74
Study 17544842 — intervention group
Group type: COMPARATOR
Intervention: 20m Multistage Shuttle Run Test (MST)
Number of subjects: 74
Study 17544842 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill test (TT)
Number of subjects: 74
Study 16791967 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12093831 — intervention group
Group type: EXPERIMENTAL
Intervention: OC + metformin
Number of subjects: 40
Study 12093831 — intervention group
Group type: COMPARATOR
Intervention: OC
Number of subjects: 40
Study 9560053 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose anthracycline-containing regimens similar to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
Number of subjects: 0
Study 9560053 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of CHOP chemotherapy followed by involved field irradiation
Number of subjects: 0
Study 9560053 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracyclines with reduced cardiotoxicity
Number of subjects: 0
Study 9560053 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic growth factors and/or cardioprotective drugs
Number of subjects: 0
Study 7643821 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study 7643821 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study 7643821 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study 7643821 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study 7643821 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study 2751841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen 0.35 mg every 12 hours
Number of subjects: 50
Study 2751841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 782977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (100.10^9 killed S. typhi)
Number of subjects: 6000
Study 782977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (300.10^9 killed S. typhi)
Number of subjects: 6000
Study 782977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (400.10^9 killed S. typhi)
Number of subjects: 6000
Study 782977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study 31302768 — intervention group
Group type: COMPARATOR
Intervention: Group I: inferior alveolar nerve block (IANB) of 2% lidocaine
Number of subjects: 90